Literature DB >> 11139321

Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs.

I F Tannock1, C Lee.   

Abstract

An increase in apoptotic cells may be observed after treatment with chemotherapy, and many authors have assumed that anti-cancer drugs kill cells by inducing apoptosis. The most relevant endpoint of cell death following treatment of tumour cells is loss of reproductive ability as measured by a colony-forming assay, since cells with limited reproductive potential cannot regenerate a tumour. We have therefore investigated the relationship between apoptosis and reproductive cell death following in vitro treatment of mammalian cell lines with anti-cancer drugs. Markers of apoptosis (DNA ladders, TUNEL assay) were evaluated at various times after treatment of Chinese Hamster Ovary (CHO) cells, human bladder cancer MGH-U1 cells, and a murine T-lymphocytic cell line (CTLL-2) with several anti-cancer drugs. These markers were found infrequently, despite the use of doses that cause loss of colony-forming ability, except in CTLL-2 cells. We also transfected and expressed the human pro-apoptotic gene bax and the anti-apoptotic gene bcl-2 in MGH-U1 cells and compared cell survival after drug treatment with that of control cells transfected with the vector alone. Expression of these genes had at most small effects to influence cell survival. We conclude that apoptotic mechanisms had at most a minor role in leading to reproductive death of MGH-U1 and CHO cells after chemotherapy. When apoptosis is observed following treatment with anti-cancer drugs it may be a secondary event which occurs in lethally-damaged cells, leading to their lysis, rather than a primary event that leads to loss of reproductive integrity. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139321      PMCID: PMC2363623          DOI: 10.1054/bjoc.2000.1538

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis.

Authors:  C Sakakura; E A Sweeney; T Shirahama; Y Igarashi; S Hakomori; H Nakatani; H Tsujimoto; T Imanishi; M Ohgaki; T Ohyama; J Yamazaki; A Hagiwara; T Yamaguchi; K Sawai; T Takahashi
Journal:  Int J Cancer       Date:  1996-07-03       Impact factor: 7.396

2.  Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing.

Authors:  T Hu; C M Miller; G M Ridder; M J Aardema
Journal:  Mutat Res       Date:  1999-05-03       Impact factor: 2.433

3.  Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival.

Authors:  R B Lock; L Stribinskiene
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

4.  Prognostic markers for colorectal cancer: expression of P53 and BCL2.

Authors:  H Pereira; S Silva; R Julião; P Garcia; F Perpétua
Journal:  World J Surg       Date:  1997-02       Impact factor: 3.352

5.  The relationship between p53 status and anticancer drugs-induced apoptosis in nine human bladder cancer cell lines.

Authors:  F L Chang; M D Lai
Journal:  Anticancer Res       Date:  2000 Jan-Feb       Impact factor: 2.480

6.  Mechanism of the selective hypoxic cytotoxicity of 1-methyl-2-nitroimidazole.

Authors:  C B Brezden; R A McClelland; A M Rauth
Journal:  Biochem Pharmacol       Date:  1994-07-19       Impact factor: 5.858

7.  Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.

Authors:  Z B Hu; G S Yang; M Li; N Miyamoto; M D Minden; E A McCulloch
Journal:  Leukemia       Date:  1995-05       Impact factor: 11.528

8.  Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

Authors:  M H Kramer; J Hermans; J Parker; A D Krol; J C Kluin-Nelemans; H L Haak; K van Groningen; J H van Krieken; D de Jong; P M Kluin
Journal:  J Clin Oncol       Date:  1996-07       Impact factor: 44.544

9.  BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells.

Authors:  D X Yin; R T Schimke
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

10.  Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response.

Authors:  D R Aldridge; M J Arends; I R Radford
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  14 in total

1.  Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.

Authors:  Emmanuel I Papadopoulos; George M Yousef; Andreas Scorilas
Journal:  Tumour Biol       Date:  2015-04-02

2.  Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.

Authors:  Daiane Teixeira DE Oliveira; Andre Luiz Ventura Savio; Joao Paulo DE Castro Marcondes; Tatiane Martins Barros; Ludmila Correia Barbosa; Daisy Maria Favero Salvadori; Glenda Nicioli DA Silva
Journal:  J Biosci       Date:  2017-03       Impact factor: 1.826

3.  Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines.

Authors:  Simon Mahoney; Frank Arfuso; Pierra Rogers; Susan Hisheh; David Brown; Michael Millward; Arun Dharmarajan
Journal:  J Biosci       Date:  2012-03       Impact factor: 1.826

Review 4.  Linking the history of radiation biology to the hallmarks of cancer.

Authors:  Mary-Keara Boss; Robert Bristow; Mark W Dewhirst
Journal:  Radiat Res       Date:  2014-05-08       Impact factor: 2.841

5.  Determine the effect of p53 on chemosensitivity.

Authors:  Emir Senturk; James J Manfredi
Journal:  Methods Mol Biol       Date:  2013

6.  Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937.

Authors:  Nathalie Perek; Odile Sabido; Nathalie Le Jeune; Nathalie Prevot; Jean-Michel Vergnon; Anthony Clotagatide; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-13       Impact factor: 9.236

7.  Quantitative immunohistochemistry for evaluating the distribution of Ki67 and other biomarkers in tumor sections and use of the method to study repopulation in xenografts after treatment with paclitaxel.

Authors:  Andrea S Fung; James Jonkman; Ian F Tannock
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715

8.  Apoptosis and survival.

Authors:  Manjul Tiwari
Journal:  Indian J Hum Genet       Date:  2011-09

9.  Recurrent growth factor starvation promotes drug resistance in human leukaemic cells.

Authors:  K Saeki; E Okuma; A Yuo
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

10.  The role of apoptotic cell death in the radiosensitising effect of gemcitabine.

Authors:  B Pauwels; J B Vermorken; A Wouters; J Ides; S Van Laere; H A J Lambrechts; G G O Pattyn; K Vermeulen; P Meijnders; F Lardon
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.